CoChat

ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer

Open access
Chan, Tim Hon Man, Qamra, Aditi, Tan, Kar Tong, Guo, Jing, Yang, Henry, Qi, Lihua, Lin, Jaymie Siqi, Ng, Vanessa Hui En, Song, Yangyang, Hong, Huiqi, Tay, Su Ting, Liu, Yujing, Lee, Jeeyun, Rha, Sun Yong, Zhu, Feng, So, Jimmy Bok Yan, Teh, Bin Tean, Yeoh, Khay Guan, Rozen, Steve, Tenen, Daniel G., Tan, Patrick, Chen, Leilei · 2016 · Gastroenterology
Cited by 182

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUD & AIMS: Gastric cancer (GC) is the third leading cause of global cancer mortality. Adenosine-to-inosine RNA editing is a recently described novel epigenetic mechanism involving sequence alterations at the RNA but not DNA level, primarily mediated by ADAR (adenosine deaminase that act on RNA) enzymes. Emerging evidence suggests a role for RNA editing and ADARs in cancer, however, the relationship between RNA editing and GC development and progression remains unknown. METHODS: In this study, we leveraged on the next-generation sequencing transcriptomics to demarcate the GC RNA editing landscape and the role of ADARs in this deadly malignancy. RESULTS: Relative to normal gastric tissues, almost all GCs displayed a clear RNA misediting phenotype with ADAR1/2 dysregulation arising from the genomic gain and loss of the ADAR1 and ADAR2 gene in primary GCs, respectively. Clinically, patients with GCs exhibiting ADAR1/2 imbalance demonstrated extremely poor prognoses in multiple independent cohorts. Functionally, we demonstrate in vitro and in vivo that ADAR-mediated RNA misediting is closely associated with GC pathogenesis, with ADAR1 and ADAR2 playing reciprocal oncogenic and tumor suppressive roles through their catalytic deaminase domains, respectively. Using an exemplary target gene PODXL (podocalyxin-like), we demonstrate that the ADAR2-regulated recoding editing at codon 241 (His to Arg) confers a loss-of-function phenotype that neutralizes the tumorigenic ability of the unedited PODXL. CONCLUSIONS: Our study highlights a major role for RNA editing in GC disease and progression, an observation potentially missed by previous next-generation sequencing analyses of GC focused on DNA alterations alone. Our findings also suggest new GC therapeutic opportunities through ADAR1 enzymatic inhibition or the potential restoration of ADAR2 activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2016.06.043

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 182

Metadata

Authors
Chan, T. H. M., Qamra, A., Tan, K. T., Guo, J., Yang, H., Qi, L., Lin, J. S., Ng, V. H. E., Song, Y., Hong, H., Tay, S. T., Liu, Y., Lee, J., Rha, S. Y., Zhu, F., So, J. B. Y., Teh, B. T., Yeoh, K. G., Rozen, S., Tenen, D. G., Tan, P., & Chen, L.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2016-10
Volume
151
Issue
4
Pages
637-650.e10
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2462382383
Cited by
182
References
5
FWCI
7.52
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. https://app.cochat.ai/papers/10.1053/j.gastro.2016.06.043
The paper
Chan, T. H. M., Qamra, A., Tan, K. T., Guo, J., Yang, H., Qi, L., Lin, J. S., Ng, V. H. E., Song, Y., Hong, H., Tay, S. T., Liu, Y., Lee, J., Rha, S. Y., Zhu, F., So, J. B. Y., Teh, B. T., Yeoh, K. G., Rozen, S., . . . Chen, L. (2016). ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. Gastroenterology. https://doi.org/10.1053/j.gastro.2016.06.043

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.